-
Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001
Janssen, L. L. G., Westers, T. M., Rovers, J., Valk, P. J. M., Cloos, J., de Gruijl, T. D. & van de Loosdrecht, A. A., 2 Nov 2023, In: HemaSphere. 7, 11, p. E968Research output: Contribution to journal › Letter › Academic › peer-review
- All publications
